Kegg medicus dgroup
| DG02891 | |
| DG番号 | DG02891 |
| 分類 | DGroup |
| 名称 | CYP2B6 inducer TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | D00896 Efavirenz (JAN/USP/INN) D11521 Lamivudine, nevirapine and zidovudine D10564 Amenamevir (JAN/INN) DG00845 Phenobarbital D00506 Phenobarbital (JP18/USP/INN) D00701 Phenobarbital sodium (JAN/USP/INN) D08356 Phenobarbital diethylamine DG00846 Phenytoin D00512 Phenytoin (JP18/USP/INN) D02103 Phenytoin sodium (USP); Phenytoin sodium for injection (JP18) DG00847 Fosphenytoin D07993 Fosphenytoin (INN) D02096 Fosphenytoin sodium (USP) D07595 Fosphenytoin sodium hydrate (JAN) D07583 Phenytoin and phenobarbital D01832 Modafinil (JAN/USP/INN) DG00999 Methadone D08195 Methadone (BAN) D02102 Methadone hydrochloride (JAN/USP) DG01840 Isavuconazonium D10644 Isavuconazonium (USAN) D10643 Isavuconazonium sulfate (JAN/USAN) |
| 上位グループ | Metabolizing enzyme inducer |
| 注釈1 | - |
| 注釈2 | - |